Autres langues Chimeric Therapeutics Limited

Actions

CHM

AU0000121576

Marché Fermé - Australian S.E. Autres places de cotation 08:10:12 03/05/2024			Varia. 5j.	Varia. 1 janv.
0,029 ^AUD	0,00%		-3,33%	-17,14%

02/05	Chimeric Therapeutics nomme un directeur de l'exploitation ; les actions augmentent de 4 %.	MT
01/05	Le PDG et directeur général de Chimeric Therapeutics démissionne ; les actions chutent de 20 %.	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Chimeric Therapeutics Appoints COO; Shares Rise 4%	02/05
Chimeric Therapeutics' CEO/Managing Director Steps Down; Shares Plunge 20%	01/05
Chimeric Therapeutics Obtains Patent Application Covering CORE-NK Technology; Shares Up 3%	05/04
Chimeric Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
Chimeric Therapeutics Treats First Patient in Phase 1B Leukemia Trial	08/02
Chimeric Therapeutics to Raise AU$3.2 Milion Via Shortfall Placement	18/01
Chimeric Therapeutics Opens Phase 1B Leukemia Trial	15/01
Chimeric Therapeutics Receives AU$7 Million R&D Tax Rebate for Fiscal Year 2023; Shares Rise 6%	10/01
Chimeric Therapeutics Secures AU$1 Million via Share Placement Deal	04/01
Chimeric Therapeutics Extends Closing Date of AU$10 Million Entitlement Offer	15/11
Chimeric Therapeutics Doses First Patient in Phase 1B Clinical Trial for Brain Cancer	02/11
Chimeric Therapeutics Announces FDA Clearance of IND Application for CHM 2101	31/10/23
Australian Shares Rebound Ahead of US Fed Policy Meeting	31/10/23
US FDA Gives Green Signal to Chimeric Therapeutics' IND Application for Gastrointestinal Cancer Drug; Shares Jump 65%	31/10/23
Chimeric Therapeutics to Raise AU$10 Million from Entitlement Offer	25/10/23
Chimeric Therapeutics Signs Deal to Support Leukemia Trial	13/09/23
Chimeric Therapeutics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
Chimeric Therapeutics Limited Announces Board Changes	30/08/23
Chimeric Therapeutics Limited Announces the Resignation of George Matcham as Non-Executive Director	03/08/23
Chimeric Therapeutics Secures Japanese Patent Allowance for Chlorotoxin	27/07/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Chimeric Therapeutics Limited

Actions

CHM

AU0000121576

Autres langues

Filtres